1. Home
  2. AAPG vs BRZE Comparison

AAPG vs BRZE Comparison

Compare AAPG & BRZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • BRZE
  • Stock Information
  • Founded
  • AAPG 2009
  • BRZE 2011
  • Country
  • AAPG China
  • BRZE United States
  • Employees
  • AAPG N/A
  • BRZE N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • BRZE Computer Software: Prepackaged Software
  • Sector
  • AAPG Health Care
  • BRZE Technology
  • Exchange
  • AAPG Nasdaq
  • BRZE Nasdaq
  • Market Cap
  • AAPG 3.6B
  • BRZE 3.1B
  • IPO Year
  • AAPG 2025
  • BRZE 2021
  • Fundamental
  • Price
  • AAPG $32.70
  • BRZE $28.69
  • Analyst Decision
  • AAPG Strong Buy
  • BRZE Strong Buy
  • Analyst Count
  • AAPG 3
  • BRZE 20
  • Target Price
  • AAPG $49.00
  • BRZE $44.65
  • AVG Volume (30 Days)
  • AAPG 8.2K
  • BRZE 1.4M
  • Earning Date
  • AAPG 11-19-2025
  • BRZE 12-08-2025
  • Dividend Yield
  • AAPG N/A
  • BRZE N/A
  • EPS Growth
  • AAPG N/A
  • BRZE N/A
  • EPS
  • AAPG N/A
  • BRZE N/A
  • Revenue
  • AAPG $54,524,554.00
  • BRZE $654,622,000.00
  • Revenue This Year
  • AAPG N/A
  • BRZE $23.36
  • Revenue Next Year
  • AAPG $368.64
  • BRZE $17.31
  • P/E Ratio
  • AAPG N/A
  • BRZE N/A
  • Revenue Growth
  • AAPG N/A
  • BRZE 22.16
  • 52 Week Low
  • AAPG $16.50
  • BRZE $23.91
  • 52 Week High
  • AAPG $48.45
  • BRZE $48.33
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 36.78
  • BRZE 54.01
  • Support Level
  • AAPG $31.01
  • BRZE $26.23
  • Resistance Level
  • AAPG $34.31
  • BRZE $28.76
  • Average True Range (ATR)
  • AAPG 0.78
  • BRZE 1.16
  • MACD
  • AAPG -0.00
  • BRZE 0.14
  • Stochastic Oscillator
  • AAPG 30.68
  • BRZE 84.91

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About BRZE Braze Inc.

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.

Share on Social Networks: